BioForce Nanosciences Ret. on equity
What is the Ret. on equity of BioForce Nanosciences?
The Ret. on equity of BioForce Nanosciences Holdings, Inc. is -762,101.27%
What is the definition of Ret. on equity?
Return on equity is a measure of the profitability of a business in relation to the book value of the shareholder equity. It is computed by dividing fiscal year net income by total shareholder equity.
ttm (trailing twelve months)
The return on equity (ROE) ROE is a measure of how well a company uses investments to generate earnings growth. ROE is used for comparing the performance of companies in the same industry. It indicated the management's ability to generate income from the equity available to it. ROEs of 15-20% are generally considered good. ROEs are also a factor in stock valuation, in association with other financial ratios. In general, stock prices are influenced by earnings per share (EPS), so that stock of a company with a 20% ROE will generally cost twice as much as one with a 10% ROE.
Ret. on equity of companies in the Consumer Staples sector on OTC compared to BioForce Nanosciences
What does BioForce Nanosciences do?
BioForce Nanosciences Holdings, Inc. focuses on providing natural vitamins, minerals, other nutritional supplements, powders, and beverages for individuals in various age ranges. The company offers private label products with distributors and manufacturing providers. It sells its nutrition supplements to retailers, sporting goods retailers, supermarkets, and mass merchandisers under the BioForce Eclipse brand, as well as through online and telemarketing. The company is based in Virginia Beach, Virginia.
Companies with ret. on equity similar to BioForce Nanosciences
- BioForce Nanosciences has Ret. on equity of -762,101.27%
- Forbes has Ret. on equity of -140,817.62%
- Asian Mineral Resources has Ret. on equity of -66,919.47%
- Safe Orthopaedics SA has Ret. on equity of -63,940.00%
- Abal plc has Ret. on equity of -48,340.56%
- Portofino Resources has Ret. on equity of -28,221.69%
- Netlinkz has Ret. on equity of -23,753.85%